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 A recent linkage analysis in a large aAutoCsComEaPlTdoEmDinaMntAPaNrkUinSsoCnR’sIdPisTease (ADPD) kindred identified a 
 
new locus for ADPD on chr.20p13. A missense Arg141Leu mutation within the TMEM230 gene has been 
suggested as causative of the disease [1]. Additional variants in the same gene have been found in two young 
onset US PD cases and seven Chinese PD patients, of which five were homozygous for the new identified 
mutation. 
Here we reported the results of a sequencing analysis of the TMEM230 gene in 86 Italian familial PD 
Caucasian patients compatible with an AD inheritance (two or more PD cases in at least two consecutive 
generations) collected between 2012 and 2016. Other patients with PD but without a history of AD 
inheritance were not included in this study. Demographic data of the patients are reported in Supplementary 
Table 1. All patients were collected at our Hospital, IRCCS Foundation Ca' Granda Ospedale Maggiore 
Policlinico, and the clinical diagnosis of PD was based on the presence of at least two of the following signs: 
bradykinesia, resting tremor and rigidity, along with a positive response to levodopa treatment and absence 
of other causes of parkinsonism. All subjects were screened for SNCA, GBA, and common LRRK2 
mutations, but we did not remove those carrying pathogenic variants from the analysis. The ethics committee 
of IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico approved the study and all patients 
provided written informed consent. To detect mutations, we performed a polymerase chain reaction of all 
exons and intron-exon boundaries of the TMEM230 gene (isoforms NM_001009923.1 and NM_014145) 
using primers reported in Supplementary Table 2. Sanger sequencing of all exons was performed. The 
identified variants were annotated according to the longer cDNA sequence deposited in Genbank (accession 
number NM_001009923.1) and their frequencies were checked in dbSNP. 
No pathogenic variants were identified. Two intronic (c.174+5G>C, c.412-44G>A) and four exonic known 
polymorphisms were detected (p.Met64Thr, p.Pro102Pro, p.Lys103Lys, p.Ala110Ala) (Supplementary 
Table 3). 
These results suggest that TMEM230 mutations are not a frequent cause of PD with AD inheritance in the 
Italian population. In the original cloning paper a single mutation was found to be present in several PD 
patients of Chinese ancestry, some in homozygous state, suggesting a high frequency of this variant in 
familial cases from that specific population. Further genetic analyses in other populations are warranted to 
detect other possible population-specific TMEM230 mutations. Furthermore, the additional variants reported 
in US patients lacking a clear co-segregation need to be confirmed in other studies. In this regard, additional 
 
 
screening in familial cases would beAimCpoCrtEanPtTinEoDrdeMr tAoNassUesSsCthReIcPo-Tsegregation of 
TMEM230 variants with PD. 
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